Annexin Pharmaceuticals AB (publ) ANNX

Updated: 13 Jun 2026

First North | Biotech | Biotech, drug development, vascular diseases

No signal published yet

We already track Annexin Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Annexin Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
First North
Type
Biotech
Sector
Biotech, drug development, vascular diseases
We're already tracking Annexin Pharmaceuticals AB (publ) — here are the latest events we've registered

Recent News

  • On June 3, 2026, Annexin resolved on a rights issue of approximately SEK 20 million to finance the ongoing Phase 2a NEXUS study until the end of the year. The issue is secured to approximately 60 percent through subscription commitments from major shareholders and management.

What Firelda Watch includes for Annexin Pharmaceuticals AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Annexin Pharmaceuticals AB (publ) will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow Annexin Pharmaceuticals AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Annexin Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Annexin Pharmaceuticals AB (publ) ANNX
Annexin Pharmaceuticals — follow and we'll monitor it
Follow Annexin Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.